Why Similar Patients Can Respond Differently and What Functional Genomics May Add to the Picture
It's one of the most familiar frustrations in personalized care: two patients follow the same nutrition, lifestyle, or wellness plan, and their results don't match. Adherence looks similar. Goals are aligned. Yet one patient thrives, and the other barely moves.
Practitioners usually work through the obvious variables first — lifestyle, environment, medical history, existing conditions. But even after accounting for all of it, something is often still missing from the picture.
Functional genomics offers another line of inquiry. Instead of treating each genetic variant as an isolated data point, it looks at how groups of variants interact across connected biological pathways — giving practitioners a systems-level view rather than a list of one-off findings.
A recent feature in TopDoctor Magazine explored how The DNA Company, based in Corona, California, built its DNA360™ report around exactly this idea.
From Isolated Variants to Connected Systems
Most genetic reports present findings one gene at a time. DNA360 takes a different approach, grouping genetic associations by the biological systems they may influence — nutrient metabolism alongside methylation and detoxification, for example, rather than as separate, disconnected results.
The report also covers areas tied to hormone processing, inflammatory response, neurotransmitter function, energy production, gut-related functions, and cellular maintenance. Seen together, these patterns can surface relationships that a single isolated result never would.
As Tracy Wood, CEO of The DNA Company, put it in the feature:
"The practitioner clinics we support are already spending hours creating individualized protocols. Through our new DNA360, these same clinics are beginning every patient relationship already knowing how they detoxify, methylate, process hormones, regulate inflammation, respond to stress, metabolize nutrients, and where their greatest inherited vulnerabilities lie. It changes every clinical conversation, and improves the health of the patient in alignment with how they were made."
Information to Guide the Conversation — Not a Treatment Decision
DNA360 doesn't diagnose, prescribe, or determine whether a therapy is right for a given patient. It's built to support the conversation — helping practitioners organize what they already know, ask sharper questions, and know where to look closer, particularly around nutrition, supplementation, hormone-related discussions, and other wellness strategies.
That distinction matters. Genetic associations, on their own, can't establish safety, need, or likely response. They're one input among several — alongside a patient's history, symptoms, labs, medications, and the practitioner's own judgment.
Or, as Wood puts it plainly: "Your genes are not diagnostic in a vacuum. They are not fatalistic."
The Real Value: A Better Next Question
Functional genomics won't explain every unexpected response, and DNA360 isn't a substitute for clinical judgment. What it offers is narrower and, in some ways, more useful — a way to organize genetic information across connected pathways so practitioners have more context when the expected result doesn't show up.
Sometimes that context reveals a question that a standard workup would have missed entirely. Sometimes it simply explains why a plan that works well for most patients isn't working for this one.
Key Takeaway
Functional genomics offers a systems-level view of genetic information, helping practitioners understand why similar patients can respond differently to the same plan. It's not a diagnostic tool, but a way to organize context and ask better questions.
Learn more about DNA360 at thednacompany.com.